761. Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022.
作者: Yunfei Li.;Suzanne M Marks.;Garrett R Beeler Asay.;Carla A Winston.;Dawn Pepin.;Susan McClure.;Nicole A Swartwood.;Ted Cohen.;C Robert Horsburgh.;Joshua A Salomon.;Nicolas A Menzies.
来源: Ann Intern Med. 2025年178卷4期479-489页
In the United States, older adults have elevated prevalence of latent tuberculosis infection (LTBI) and incidence of tuberculosis (TB).
762. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.
作者: Lisa A Brenner.;Vince Capaldi.;Joseph Constans.;Steven Dobscha.;Matthew Fuller.;Bridget Matarazzo.;Kate McGraw.;Kenneth Richter.;James Sall.;Derek Smolenski.;Scott Williams.;Sarah Davis-Arnold.;Nazanin Bahraini.
来源: Ann Intern Med. 2025年178卷3期416-425页
The U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DOD) updated the 2019 joint clinical practice guideline (CPG) for assessing and managing patients who are at risk for suicide. This synopsis provides primary care physicians with a summary of the updated 2024 recommendations regarding evaluation and management of military members and veterans at risk for suicide.
763. Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
作者: George N Ioannou.;Kristin Berry.;Nallakkandi Rajeevan.;Yuli Li.;Lei Yan.;Yuan Huang.;Hung-Mo Lin.;David Bui.;Denise M Hynes.;Mazhgan Rowneki.;Amy Bohnert.;Edward J Boyko.;Theodore J Iwashyna.;Matthew L Maciejewski.;Valerie A Smith.;Theodore S Z Berkowitz.;Ann M O'Hare.;Elizabeth M Viglianti.;Mihaela Aslan.;Kristina L Bajema.
来源: Ann Intern Med. 2025年178卷3期348-359页
Monovalent COVID-19 vaccines targeting the XBB.1.5 Omicron variant were introduced in September 2023. In the absence of randomized controlled trials demonstrating their efficacy, information on real-world vaccine effectiveness (VE) is needed.
764. In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.
GIM/FP/GP: [Formula: see text] Neurology: [Formula: see text] Hematology: [Formula: see text].
765. In arterial hypertension, renal denervation vs. a sham procedure reduces ambulatory and office BP at ≤6 mo.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Nephrology: [Formula: see text].
767. Comparative Effectiveness of Pharmacologic Treatments for the Prevention of Episodic Migraine Headache: A Systematic Review and Network Meta-analysis for the American College of Physicians.
作者: Johanna A A Damen.;Bada Yang.;Demy L Idema.;Robin W M Vernooij.;Linde Huis In 't Veld.;Mike Kusters.;Rene Spijker.;Kim van der Braak.;Pauline Heus.;Kevin Jenniskens.;Lotty Hooft.
来源: Ann Intern Med. 2025年178卷3期369-380页
Various treatments for preventing episodic migraine are available.
769. In adults with obesity and knee OA, adding weekly semaglutide to diet and activity counseling reduced weight and knee pain at 68 wk.
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text] Rheumatology: [Formula: see text].
770. Patients' Values and Preferences Regarding Pharmacologic Treatments for the Prevention of Episodic Migraine Headache: A Systematic Review for the American College of Physicians.
作者: Bada Yang.;Robin W M Vernooij.;Demy L Idema.;Linde Huis In 't Veld.;Mike P T Kusters.;Rene Spijker.;Kim van der Braak.;Pauline Heus.;Kevin Jenniskens.;Lotty Hooft.;Johanna A A Damen.
来源: Ann Intern Med. 2025年178卷3期381-388页
Decision making regarding pharmacologic treatments for the prevention of episodic migraine may depend on the importance that patients place on outcomes and specific treatment preferences.
771. Surveillance Note: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.773. Integrated suicide care in primary care improved safety planning and reduced suicide attempts at 90 d.
Mental Health: [Formula: see text] GIM/FP/GP: [Formula: see text] Public Health: [Formula: see text].
775. An intensivist-led telemedicine strategy did not reduce ICU LOS vs. usual care in critically ill patients.
GIM/FP/GP: [Formula: see text] Critical Care: [Formula: see text].
776. In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y.
GIM/FP/GP: [Formula: see text] Neurology: [Formula: see text].
778. In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
779. Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Thomas G Cooney.;Itziar Etxeandia-Ikobaltzeta.;Timothy J Wilt.;Curtis S Harrod.;Jeffrey A Tice.;Carolyn J Crandall.; .;Lauri A Hicks.;J Thomas Cross.;Nick Fitterman.;Johanna Lewis.;Amy M Linsky.;Michael Maroto.;Matthew C Miller.;Adam J Obley.;Douglas K Owens.;Paul G Shekelle.;Tatyana Shamliyan.;Jennifer Yost.
来源: Ann Intern Med. 2025年178卷3期426-433页
The American College of Physicians (ACP) developed this clinical guideline for clinicians caring for adults with episodic migraine headache (defined as 1 to 14 headache days per month) in outpatient settings.
|